drugset / Trial / NCT06917872
A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood
NaSequentialOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect of erythromycin, a moderate CYP3A4 inhibitor on the pharmacokinetics of BI 1291583 at steady state.
Timeline
- Start
- 2025-04-29
- Primary completion
- 2025-09-09
- Completion
- 2025-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1291583 | Unknown | — | — |
| Subject | Erythromycin | Small molecule | — | Oral |
Indications
No indication recorded.